Dr. Christopher De Haydu, MD

  • Miami, FL
  • OB-GYN
NPI1851738793PAC ID6305167784
Part D claims, 2024
42
Publications
13
MIPS score, 2024
89
Hospital affiliations
1
Industry payments
$7,743
Practice address
9555 Sw 162 Ave, Miami, FL 33196
Practice phone
Call (786) 467-2000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

West Kendall Baptist Hospital

Hospital · Miami, Florida

See all 6 affiliations

Find Dr. De Haydu's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Christopher De Haydu is an OB-GYN in Miami, Florida

Dr. De Haydu practices at West Kendall Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. De Haydu's NPI, 1851738793, was assigned on June 2, 2013. Dr. De Haydu graduated from Icahn School Of Medicine At Mount Sinai in 2013. Dr. De Haydu holds Florida license ME132369.

NPI and contact details
Medicare PAC ID
6305167784
NPI enumeration date
June 2, 2013
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(786) 467-2000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
39
Medical school graduation
2013

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Christopher De Haydu practices at West Kendall Baptist Hospital in Miami, Florida

Dr. De Haydu's primary practice is West Kendall Baptist Hospital, at 9555 Sw 162 Ave, Miami, FL 33196 in Miami-Dade County. The practice phone is (786) 467-2000.

Source: Dmand AI Affiliation Data

Dr. Christopher De Haydu is affiliated with 3 sites of care and 3 medical groups

Dr. De Haydu's primary practice is West Kendall Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Florida Woman Care. Dmand AI also links Dr. De Haydu to 2 more group practices and clinics and 2 medical groups, each named with a free account.

See all 6 affiliations for Dr. De Haydu

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Christopher De Haydu's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. De Haydu practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
West Kendall Baptist HospitalAvailable with a free account
+2 more sites and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. De Haydu practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Baptist Health South Florida and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Christopher De Haydu is one of 2,315 OB-GYNs in Florida

Obstetrics and gynecology is Dr. De Haydu's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. De Haydu is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dr. De Haydu is licensed in Florida.

Specialties and state licenses

  • Obstetrics and gynecology, FloridaPrimaryLicense ME132369 · 2017 to 2027 · taxonomy 207V00000X

Clinical focus

Dmand AI lists hysterectomy and menopause among the conditions Dr. De Haydu treats.

OB-GYNs near Dr. De Haydu

Counts of OB-GYNs with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Christopher De Haydu's patients have a median age of 36

Across all payers, Dmand AI patient panel data puts Dr. De Haydu's median patient age at 36, with 99% women.

Dr. De Haydu's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 36

Patient panel by sex, all payers

  • Women99%
  • Men1%

Source: Dmand AI Patient Panel Data

Dr. Christopher De Haydu wrote 42 Medicare Part D claims in 2024

In 2024, Dr. De Haydu wrote 42 Medicare Part D claims for 12 patients. 64% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $5,302 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Part D claims, 202442
Drugs named by CMS1
Total drug cost$5,302
Part D patients12

Dr. De Haydu's Part D claims by kind of drug, 2024

  • Generic27 claims64%
  • Brand-name15 claims36%

Dr. De Haydu's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. De Haydu's Part D claims, 2024

  • Antibiotics31%13 of 42 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 112024: 129%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. De Haydu

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Christopher De Haydu scored 89 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. De Haydu for performance year 2024, reported as part of a group. Dr. De Haydu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. De Haydu's MIPS scores, performance year 2024

  • 89of 100Final score
  • 84.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 78of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find OB-GYNs like Dr. De Haydu by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Christopher De Haydu has 13 publications on record

Dmand AI links 13 papers to Dr. De Haydu, published from 2015 to 2021. 2016 was the busiest year, with 4. The most frequent topics are Antineoplastic Agents, Cell Line, Tumor and Disease Models, Animal. Dr. De Haydu has published most often in Mol Cancer Ther. Dr. De Haydu's most frequent co-authors are Jonathan D. Black, MD, MPH, Alessandro D. Santin, MD and Masoud Azodi, MD.

Papers13
Years published2015 to 2021

Dr. De Haydu's papers by year, 2015 to 2021

Topics Dr. De Haydu writes about most

  • Antineoplastic Agents
  • Cell Line, Tumor
  • Disease Models, Animal
  • Cell Survival
  • Gene Expression
  • Ovarian Neoplasms
  • Receptor, ErbB-2
  • Xenograft Model Antitumor Assays

Dr. De Haydu's most frequent co-authors

Recent publications by Dr. De Haydu

See all 13 publications and co-authors

See who Dr. De Haydu researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. De Haydu works with, so you can find a warm path to the right OB-GYNs.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Christopher De Haydu received $7,743 in industry payments from 2019 to 2025

CMS Open Payments shows 45 general payments to Dr. De Haydu from 15 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Sumitomo Pharma America, Inc. paid the most, $6,285.

General payments to Dr. De Haydu by program year, 2019 to 2025

General payments to Dr. De Haydu by kind, 2019 to 2025

$7.7Kin total
  • Speaker and faculty fees$6,22880%
  • Food and beverage$1,37318%
  • Education$1432%

Companies that paid Dr. De Haydu the most, 2019 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. De Haydu

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Christopher De Haydu graduated from Icahn School Of Medicine At Mount Sinai

Dr. De Haydu graduated from Icahn School Of Medicine At Mount Sinai in 2013.

  1. Medical schoolIcahn School Of Medicine At Mount Sinai
  2. Board certified in obstetrics & gynecologyAmerican Board of Obstetrics and Gynecology

Source: Dmand AI Professional Profile Data

Dr. Christopher De Haydu accepts plans from 14 insurance carriers

Dr. De Haydu is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Elevance
  • HCSC
  • Aspirus Health Plan
  • Blue Cross Blue Shield of Massachusetts
  • Molina
  • +6 more carriersWith a free account

Plan types Dr. De Haydu accepts, by number of carriers

  1. PPO9
  2. HMO8
  3. Medicare6
  4. EPO4
  5. POS4

Source: Dmand AI Insurance Network Data

Sources for Dr. Christopher De Haydu's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Christopher De Haydu

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Christopher De Haydu's NPI number?

Dr. Christopher De Haydu's NPI number is 1851738793. It was assigned on June 2, 2013, and it is active in the NPI Registry.

What kind of doctor is Dr. Christopher De Haydu?

Dr. Christopher De Haydu is an OB-GYN in Miami, Florida. The primary specialty in the NPI Registry is Obstetrics & Gynecology Physician (taxonomy code 207V00000X).

Where does Dr. Christopher De Haydu practice?

Dr. De Haydu practices at 9555 Sw 162 Ave, Miami, FL 33196. Dr. De Haydu's primary practice is West Kendall Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dmand AI also links Dr. De Haydu to 2 group practices and clinics and 2 medical groups.

What is Dr. Christopher De Haydu's office phone number?

The practice phone on file for Dr. De Haydu is (786) 467-2000.

What is Dr. Christopher De Haydu's medical license number?

Dr. De Haydu holds Florida license ME132369.

Which hospitals is Dr. Christopher De Haydu affiliated with?

Dr. De Haydu practices at West Kendall Baptist Hospital in Miami, Florida.

What medical group is Dr. Christopher De Haydu part of?

Dr. De Haydu is linked to Florida Woman Care. Dmand AI links Dr. De Haydu to 2 more medical groups.

Does Dr. Christopher De Haydu accept Medicare?

Yes. CMS lists Dr. De Haydu as accepting Medicare assignment.

What is Dr. Christopher De Haydu's MIPS score?

Dr. De Haydu's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.

Is Dr. Christopher De Haydu board certified?

Yes. Dr. De Haydu is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology.

Show 7 more questionsShow fewer questions

Where did Dr. Christopher De Haydu go to medical school?

Dr. De Haydu graduated from Icahn School Of Medicine At Mount Sinai in 2013.

What drugs does Dr. Christopher De Haydu prescribe most?

In 2024 Medicare Part D data, Dr. De Haydu's most prescribed drugs by claims were Premarin.

Has Dr. Christopher De Haydu received payments from drug or device companies?

CMS Open Payments shows $7,743 in general payments to Dr. De Haydu from 15 companies from 2019 to 2025. The largest total came from Sumitomo Pharma America, Inc.

How long has Dr. Christopher De Haydu been practicing?

Dr. De Haydu graduated from medical school in 2013, 13 years ago.

Does Dr. Christopher De Haydu do research?

Dmand AI links 13 publications to Dr. De Haydu, published from 2015 to 2021.

Who does Dr. Christopher De Haydu publish with?

Dr. De Haydu's most frequent co-authors are Jonathan D. Black, MD, MPH (5 shared papers), Alessandro D. Santin, MD (5 shared papers) and Masoud Azodi, MD (4 shared papers).

What insurance does Dr. Christopher De Haydu accept?

Dr. De Haydu is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to obstetrics and gynecology practices?

See OB-GYNs in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)